Mia's Feed
Medical News & Research

Innovative AI-Based Rapid Testing for Viral Infections

Innovative AI-Based Rapid Testing for Viral Infections

Share this article

A new AI-driven nanopore test enables quick and accurate detection of live viruses within minutes, promising to enhance viral infection diagnosis and treatment.

1 min read

Researchers have developed a groundbreaking non-DNA based diagnostic test that can detect viral infections within minutes. Traditionally, confirming the presence of a virus involves DNA sequencing tests, which, although accurate, take several hours and cannot determine whether the detected virus is viable. This new method, described in a recent study published in PNAS Nexus, offers a faster alternative by analyzing virus particles as they pass through a nanopore, measuring their electrical conductivity, size, surface charge, and molecular structure.

The test utilizes an AI-powered system that interprets electrical conductivity waveforms, enabling it to identify different viruses, even distinguishing among viruses within the same family. In trials focused on herpesvirus infections that can cause ocular diseases leading to blindness, the AI nanopore system achieved a sensitivity of 100%, with specificity improving over time to more than 90% under optimized conditions.

This technology has promising implications for rapid viral diagnosis, especially in ocular conditions and potentially other infectious diseases. As it matures, it could significantly enhance clinicians' ability to quickly detect and treat viral infections, ultimately improving patient outcomes.

The study was conducted by Noriyasu Hashida and colleagues, highlighting how this innovative approach could transform infectious disease diagnostics in clinical settings.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Discovery of Protein Switch for Regulating Viral and Autoimmune Immune Responses Offers Therapeutic Potential

Scientists have uncovered a vital protein switch involving SLIRP that controls immune responses to viruses and autoimmune diseases, highlighting new therapeutic possibilities for immune regulation.

Gene 'Switches' Can Be Edited to Modulate Inflammation, Paving the Way for New Therapies

Scientists have successfully manipulated epigenetic marks on immune-related genes using CRISPR technology, opening new possibilities for treating inflammatory diseases and cancer.